An Update on Animal Models of Alcohol-Associated Liver Disease
The American Journal of Pathology · 2026-01 · 196 (1) · 4-19
DOI: 10.1016/j.ajpath.2024.11.011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The American Journal of Pathology, 2026-01. Verfasst von Peng Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas. Hauptthemen laut MEDLINE: Disease Models, Animal, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIA NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
Alcohol-associated liver disease (ALD) is a significant global health concern and a leading cause of liver disease-related deaths. However, the treatment options are limited due to the lack of animal models that accurately replicate ALD pathogenesis. An ideal ALD animal model should have pathological characteristics similar to those of human ALD, with a clear pathological process and ease of drug intervention. Over the years, researchers have focused on developing ideal ALD preclinical animal models by testing various methods, such as ad libitum drinking water with ethanol, acute, single large doses of ethanol gavage, multiple alcohol gavages in a short period, the Lieber-DeCarli liquid diet feeding model, the intragastric infusion model, and the Gao-binge model. With the increasing occurrence of obesity and metabolic dysfunction-associated steatotic liver disease, a new category of metabolic and alcohol-associated liver disease (MetALD) is also emerging. Studies have investigated the combined effects of a high-fat diet combined with binge alcohol or drinking water containing ethanol to mimic MetALD. In addition to mice, other species such as rats, guinea pigs, zebrafish, and non-human primates have also been tested to establish ALD preclinical models. This review aims to summarize current animal ALD models, particularly the emerging MetALD models, with the hope of providing a valuable reference for establishing more effective animal models in ALD studies in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
- Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas; Division of Gastroenterology, Hepatology & Mobility, Department of Internal Medicine, University of Kans…
Förderung
- NIAAA NIH HHS
- NIA NIH HHS
- National Institute on Aging
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Cao, P., Chao, X., Ni, H. M., & Ding, W. X. (2026). An Update on Animal Models of Alcohol-Associated Liver Disease. The American Journal of Pathology, 196(1), 4-19. https://doi.org/10.1016/j.ajpath.2024.11.011
Vancouver
Cao P, Chao X, Ni HM, Ding WX. An Update on Animal Models of Alcohol-Associated Liver Disease. The American Journal of Pathology. 2026;196(1):4-19. doi:10.1016/j.ajpath.2024.11.011
BibTeX
@article{Cao2026,
author = {Cao, Peng and Chao, Xiaojuan and Ni, Hong-Min and Ding, Wen-Xing},
title = {An Update on Animal Models of Alcohol-Associated Liver Disease},
journal = {The American Journal of Pathology},
year = {2026},
volume = {196},
number = {1},
pages = {4--19},
doi = {10.1016/j.ajpath.2024.11.011}
}
EUVIMED